BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11536173)

  • 41. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
    Graham DB; Bell MP; McCausland MM; Huntoon CJ; van Deursen J; Faubion WA; Crotty S; McKean DJ
    J Immunol; 2006 Jan; 176(1):291-300. PubMed ID: 16365421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activation.
    Meinl E; Derfuss T; Pirzer R; Blank N; Lengenfelder D; Blancher A; Le Deist F; Fleckenstein B; Hivroz C
    J Biol Chem; 2001 Oct; 276(40):36902-8. PubMed ID: 11463783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
    Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
    J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis.
    Bida AT; Upshaw Neff JL; Dick CJ; Schoon RA; Brickshawana A; Chini CC; Billadeau DD
    Mol Immunol; 2011 May; 48(9-10):1149-59. PubMed ID: 21439641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta.
    Kruse M; Meinl E; Henning G; Kuhnt C; Berchtold S; Berger T; Schuler G; Steinkasserer A
    J Immunol; 2001 Aug; 167(4):1989-95. PubMed ID: 11489980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The SAP family: a new class of adaptor-like molecules that regulates immune cell functions.
    Veillette A
    Sci STKE; 2002 Feb; 2002(120):pe8. PubMed ID: 11854537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
    Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
    J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
    Howie D; Sayos J; Terhorst C; Morra M
    Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes.
    Punnonen J; Cocks BG; Carballido JM; Bennett B; Peterson D; Aversa G; de Vries JE
    J Exp Med; 1997 Mar; 185(6):993-1004. PubMed ID: 9091591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor.
    Chen R; Latour S; Shi X; Veillette A
    Mol Cell Biol; 2006 Aug; 26(15):5559-68. PubMed ID: 16847311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes.
    Veillette A; Dong Z; Latour S
    Immunity; 2007 Nov; 27(5):698-710. PubMed ID: 18031694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
    Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
    J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
    Ma CS; Nichols KE; Tangye SG
    Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SAP: natural inhibitor or grand SLAM of T cell activation?
    Nichols KE; Koretzky GA; June CH
    Nat Immunol; 2001 Aug; 2(8):665-6. PubMed ID: 11477397
    [No Abstract]   [Full Text] [Related]  

  • 58. Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.
    Zhao F; Cannons JL; Dutta M; Griffiths GM; Schwartzberg PL
    Immunity; 2012 Jun; 36(6):1003-16. PubMed ID: 22683123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SLAM and its role in T cell activation and Th cell responses.
    Aversa G; Carballido J; Punnonen J; Chang CC; Hauser T; Cocks BG; De Vries JE
    Immunol Cell Biol; 1997 Apr; 75(2):202-5. PubMed ID: 9107577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.
    Snow AL; Marsh RA; Krummey SM; Roehrs P; Young LR; Zhang K; van Hoff J; Dhar D; Nichols KE; Filipovich AH; Su HC; Bleesing JJ; Lenardo MJ
    J Clin Invest; 2009 Oct; 119(10):2976-89. PubMed ID: 19759517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.